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A R T I C L E
Th e impact of Austrian pharmaceutical 




During the nineteenth century the formation of phar-
maceutical societies greatly infl uenced the development 
of pharmacy in Austria. Such societies were needed to 
address the economic, social and educational diffi  cul-
ties faced by pharmacists. Th ey resulted from the low 
pay of assistant pharmacists, the lack of an old age pen-
sion scheme, the absence of health insurance, the non-
availability of fi nancial support for widows and or-
phans, and the low profi le of pharmacists caused by the 
inadequate education of apothecaries, assistant phar-
macists and apprentices. Th is article describes the ori-
gins of the more prominent pharmaceutical societies in 
the German language and their eff ect on Austrian 
pharmacy.
Zusammenfassung
Während des 19. Jahrhunderts nahmen pharmazeutische 
Gesellschaften großen Einfl uss auf die Entwicklung der 
österreichischen Pharmazie. Zu jener Zeit waren die 
Pharmazeuten mit ökonomischen und sozialen Proble-
men und einer unzureichenden fachlichen Ausbildung 
konfrontiert. Die niedrige Bezahlung der Assistenten 
sowie das Fehlen einer Altersversorgung und einer 
Krankenversicherung für das pharmazeutische Personal 
und deren Familien und der mangelhafte 
pharmazeutische Unterricht führten zur Entstehung 
pharmazeutischer Gesellschaften, die eine Lösung der 
Probleme zum Ziel hatten. Der Artikel informiert über 
die Entstehung der wichtigsten deutschsprachigen 
pharmazeutischen Gesellschaften und ihren Einfl uss auf 
die österreichische Pharmazie.
Introduction
Th e history of pharmacy in Austria is closely allied to 
the country’s social, political and economic history, 
which is therefore now briefl y described. Th e House of 
Hapsburg dominated the history of Austria over centu-
ries, from the end of the thirteenth century until 1918. 
Th e Hapsburg dynasty established a powerful empire 
in Europe which included a wide range of territories 
situated in southern, central and eastern Europe. Th e 
size of the empire changed constantly depending on the 
territories conquered by wars or gained by marriages or 
lost again after armed confl icts. Th e representatives of 
the dynasty held the titles of kings, archdukes, dukes, 
counts, and so on of the diff erent territories which com-
prised the empire. Without interruption they were the 
elected emperors of the Holy Roman Empire since the 
fi fteenth century, except for the brief period between 
1742 and 1745.
At the turn of the nineteenth century the armed 
confl icts between the Hapsburg Empire and France re-
sulted in the defeat of the Hapsburg Empire and the 
loss of territories. Napoleon even demanded that the 
Hapsburg Emperor, Franz II (1768-1835) resign as em-
peror of the Holy Roman Empire. In the wake of the 
coronation of Napoleon as Emperor of France in 1804, 
Franz II proclaimed the Austrian Empire soon after. He 
adopted the title Franz I, Emperor of Austria. In 1806 
he abandoned the position of emperor of the Holy Ro-
man Empire, declaring concurrently the empire’s dis-
bandment. He took this measure after sixteen members 
of the Imperial Federation left to join together as a 
Rhine alliance under French protectorate.
Th e downfall of Napoleon led to a change in the 
balance of power in Europe. Th e Austrian Foreign 
Minister Clemens Wenzel von Metternich (1773-1859) 
organized an all-European congress in Vienna (the so 
called Viennese Congress of 1814/1815) where a new 
political order in Europe was to be set up. One result 
of the congress was the formation of the German Fed-
eration, which solved the problem of the German ter-
ritories without creating one powerful German state. It 
was a federation of sovereign states deciding by major-
ity vote. Th e Austrian Empire played a leading role in 
the federation and presided the meetings of the mem-
bers. Th e confl icts between the main powers of the fed-
eration, the Kingdom of Prussia and the Austrian Em-
pire, led to the end of the German Federation in 1866.
Th roughout the nineteenth century the Austrian 
Empire had to deal with armed confl icts and a growing 
nationalism within the borders of the Empire. In 1867 
the Hungarians achieved autonomy in a dual monar-
chy, henceforth known as the Austro-Hungarian Mon-
archy. However the problems continued due to the un-
settled claims of the Slavic countries. Finally, the 
Austro-Hungarian Monarchy collapsed in 1918 after 
having lost the First World War.
In October 1918 the fi rst government of German 
Austria (Deutschösterreich) was formed. In October 
1919, in Saint-Germain-en-Laye, France, the allies from 
the First World War and Austria signed a treaty, which 
amongst other things prohibited Austria from uniting 
with Germany, and ordered the assignment of territo-
rial claims to the neighbouring countries. Th e borders 
of the new republic embraced more or less the territory 
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of present-day Austria. In November 1919 the offi  cial 
name became “Republic of Austria”.
Th e First Austrian Republic struggled against severe 
economic and political problems, and ended in 1938 
when she was annexed to the German Reich. Following 
the end of the Second World War she again became a 
republic in 1945. For ten years the Republic of Austria 
had been put under the control of the military admin-
istration of the four victorious nations – Great Britain, 
France, Russia and the United States. In 1955 Austria 
again gained full independence after successful nego-
tiations with the Allies. She joined the European Union 
in 1995. Today Austria shares borders with eight other 
countries; Switzerland and Liechtenstein to the west, 
Germany and the Czech Republic, to the north, Slova-
kia and Hungary to the east, Slovenia and Italy to the 
south.
Societies in Austria before 1848
Pharmaceutical societies as such did not exist in Austria 
until the mid-nineteenth century. Th e absolute sover-
eigns of the Empire did not tolerate societies, because 
they feared such bodies could produce subversive ideas, 
which might destabilize the country and undermine the 
power of the authorities. To emphasize imperial author-
ity a directive of 1764 banned the founding of any so-
ciety which did not have the approval of the sovereign.
However, in the wake of the French revolution in 
1789 it was no longer possible to suppress the spirit of 
enlightenment. Societies for readers of journals and pa-
pers on particular topics had to be tolerated, and socie-
ties with humanitarian aims, stock corporations and 
societies with economic goals were also admitted.1, 2 Th e 
subsequent formation of all other societies in Austria 
resulted from the ending of the rigid censorship that 
was imposed until 1848.
Th e fi rst half of the nineteenth century – during the 
time of the Austrian Empire – was characterised by po-
litical and social tensions in Austria. Th ese tensions 
emerged from the bad economic situation which fol-
lowed two economic crises and crop failures; these had 
produced infl ation, famine and agitation, especially 
amongst the workers and farmers. Th e middle classes 
and the intelligentsia wanted to have more infl uence on 
economic questions, and yearned for personal freedom 
and democracy.
On 13 March 1848 citizens and students assaulted 
the legislative body in Vienna, seized the building and 
forced the government to resign. Th e riots by citizens 
and workers which followed created further public ag-
itation and eventually led to revolution.
To stop the rebellion the Emperor, Ferdinand I 
(1793-1875) gave in. Ferdinand had been Emperor of 
Austria since 1835 and remained so until his abdication 
in December 1848. On 15 March 1848 he retracted the 
hated censorship, guaranteed the freedom of the press, 
and promised a constitution and the formation of a na-
tional guard.3 Unfortunately, the political events that 
followed caused another revolution in October 1848, 
which was ruthlessly put down.4 Afterwards, gatherings 
by groups of people and the founding of societies were 
forbidden.
Six months later, on 4 March 1849 the new Em-
peror, Franz Joseph I (1830-1916) – who reigned until 
his death in 1916 – enforced a new set of regulations. 
Th ese regulations guaranteed the freedom of the press 
and teaching, and the right to found any society with-
out subversive or unlawful intentions.5 Two weeks later 
another imperial directive guaranteed the unfettered 
formation of non-political, non-profi t societies, provid-
ed they solely pursued scientifi c or humanitarian goals.6 
But in 1852 a new law again limited the activities of 
societies.7 However in 1867, according to a new law re-
lating to societies, non-profi t societies could be formed 
freely, although they needed to submit detailed statutes 
to the Ministry of the Interior for approval.8
Problems facing Austrian pharmacists in the nine-
teenth century
Th e problems prevalent in Austria in the fi rst half of the 
nineteenth century also aff ected apothecaries and their 
assistant pharmacists. Austrian pharmacies and the 
Figure 1. Rebellion in Vienna on 13 March 1848. 
(Source: Austrian National Library, Vienna, Austria)
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staff  who worked in them faced a bad economic situa-
tion. Th is resulted mainly from the wars that Austria 
waged. Th e people had little money to buy medicines, 
the physicians prescribed cheap ingredients due to the 
shortage of foreign drugs, and the pharmacies had to 
compete with many herbalists and quacks, who sold 
medicines of questionable quality to the public.
Another problem was the poor pharmaceutical edu-
cation at the time. Th e professional knowledge of the 
apprentices and journeymen relied mainly on that of 
their masters, because university courses were only 
compulsory for those journeymen who intended to run 
a pharmacy. Furthermore, the teaching of pharmacists 
refl ected the necessities of medicine more than those of 
pharmacy. Finally, in 1853 a full course of study of 
pharmacy was established at the university in Vienna 
and also at the universities in Prague, Pesth, Cracow, 
Graz, Innsbruck and Lemberg.9 Only in 1922 did the 
study of pharmacy become mandatory for all pharma-
cists working in a pharmacy.10
From the beginning of the nineteenth century until 
the reform of pharmacy education in 1922, pharmacy 
staff  in Austria comprised personnel of very diff erent 
educational levels. Th ere were assistant pharmacists 
who had worked as apprentices and later attended 
courses at the university or enrolled in the study of 
pharmacy at the university. But other assistant pharma-
cists had only undertaken an apprenticeship, and had 
afterwards enlarged their pharmaceutical knowledge by 
working in a pharmacy.
Another issue was the subordination of the apoth-
ecaries to the physicians, because pharmaceutical aff airs 
were simply of no importance to the infl uential medical 
faculty of the University of Vienna. Pharmacists were 
not present in administrative bodies, and had very lit-
tle infl uence on the public health authorities. Further-
more, pharmacy employees suff ered poor working con-
ditions with low wages, had no health insurance and 
no pension scheme.
Consequently the pharmacists tried to improve 
their situation. Th ey gathered in societies to join forces 
and to take measures to enhance their chances of 
achieving reform.
Early Pharmaceutical Societies before 1848
Th ere is some limited evidence that the beginnings of 
pharmaceutical societies in Austria pre-date 1848. 
Th ere have been claims of a report regarding a “medi-
Figure 2. Revolution in Vienna on 31 October 1848. (Source: Austrian National Library, Vienna, Austria)
https://doi.org/10.24355/dbbs.084-202007291249-0
60 PHARMACEUTICAL HISTORIAN  ·  2018  ·  Volume 48/3
cal-surgical-pharmaceutical reader circle” established 
about 1790 in the city of Linz in Upper Austria; how-
ever, the existence of this report has been questioned.11 
Th e fi rst traceable Austrian pharmaceutical reader circle 
appeared in 1802 in Vienna. It was founded by Joseph 
Moser, who was an apothecary in Vienna and an ex-
ecutive of the Viennese Apothecary Board between 
1816 and 1836.12 Th e hard economic times meant that 
interested apothecaries and their pharmaceutical staff  
could barely aff ord to buy the expensive pharmaceuti-
cal journals and manuals available to keep up to date 
with scientifi c progress. Hence, sharing the literature 
for a small fee allowed them easily to get all the infor-
mation they needed about the latest fi ndings in phar-
macy and medicine.
Other pharmaceutical and chemical reader circles 
followed some years later. Adolf Martin Pleischl – who 
was professor in general and pharmaceutical chemistry 
at the University of Prague –established a reader circle 
whose formation was announced in 1823.13 Another 
reader circle was established in 1830 in the city of Linz 
in Upper Austria.14
Martin Ehrmann (1795-1870) and his impact on 
Austrian pharmacy
Martin Ehrmann was one of the most active propo-
nents for reform in all fi elds of Austrian pharmacy. He 
was educated as a pharmacist in Friedek in Silesia (to-
day this is Frýdek-Mistek in the Czech Republic), and 
worked later as an assistant pharmacist in a pharmacy 
in his hometown of Brno, Southern Moravia (today 
Brno is the second largest city in the Czech Republic). 
Moravia belonged to the Hapsburg Empire since the 
sixteenth century.
In 1819 Ehrmann went to Vienna to attend the 
pharmaceutical course at the university, where he grad-
uated in 1821. He continued his studies in natural sci-
ences, especially in chemistry, at the polytechnic insti-
tute in Vienna. Th ree years later he received the degree 
of Doctor of Chemistry from the University of Vienna. 
In the same year the university appointed him as an ex-
traordinary professor to hold lectures on medicinal in-
gredients and chemistry. In 1827 the faculty also per-
mitted him to teach pharmacy. He published several 
books, some of which became recommended text books 
for pharmacy students.15, 16
Ehrmann was a forward-looking man who was 
aware of the upcoming challenges the pharmaceutical 
profession had to meet. Consequently, in 1827 he sug-
gested the establishment of a pharmaceutical institute 
and of a laboratory at the university. However, the pro-
fessor for botany and chemistry – Franz Joseph von Jac-
quin – and the professor for natural history – Johann 
Baptist Andreas Scherer – both opposed these propos-
als. Ehrmann’s other projects (establishing a pharma-
ceutical journal, forming a pharmaceutical society, and 
establishing a welfare institution for needy pharmacists) 
failed likewise, due to the opposition of the Viennese 
Apothecary Board.
In 1834 Ehrmann started publishing his own jour-
nal entitled “Th e latest and most important fi ndings in 
pharmacy and in basic sciences” (Das Neueste und Wis-
senswertheste aus dem Umfang der Pharmacie und ihrer 
Grundwissenschaften). Accordingly, he included in it in-
formation about the latest fi ndings in chemistry and 
medicinal drugs and general pharmaceutical aff airs. 
Th e last issue of this journal was published in 1845.17
In 1836 Ehrmann moved to the city of Olmütz (to-
day Olomouc in Moravia in the Czech Republic) to ac-
cept the newly installed chair in “medical propaedeu-
tics” (Chirurgische Vorbereitungswissenschaften-an 
introductory course) at the Franzens University. Th ere 
he taught chemistry, botany and physics to surgeons 
and held the position of rector at that university in 
1846.18 Despite his new professional tasks, he retained 
his close connections to pharmacy.
Figure 3. Martin Ehrmann 1795 (Brno)  ̶ 1870 
(Vienna) (Source: Austrian National Library, Vienna, 
Austria)
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Martin Ehrmann and the Austrian Journal of Phar-
macy, 1847
During the short liberal period between March and 
October 1848 pharmacists articulated their problems 
openly in the “Austrian Journal for Pharmacy” (Öster-
reichische Zeitschrift für Pharmacie). Th is was published 
by Martin Ehrmann. Since 1847 the journal had dis-
seminated new scientifi c fi ndings as well as information 
about matters of professional importance.
Another forum to freely discuss urgent problems in 
Austrian pharmacy – in particular those of pharmacy 
owners – was the Austrian Apothecary Congress organ-
ised by the Austrian Apothecary Board and held in Vi-
enna in September 1848. During that conference the 
participants discussed various problems of Austrian 
pharmacy, and agreed to establish a pharmaceutical so-
ciety in order to have a platform to discuss all scientifi c 
and professional questions. Martin Ehrmann’s above-
mentioned “Austrian Journal for Pharmacy” was ac-
cepted as the future society’s journal.19
Th e Moravian Apothecary Society, 1855
In March 1849 Ehrmann initiated the formation of the 
Austrian Apothecary Society in accordance with the 
decision of the Austrian Apothecary Congress held in 
September 1848 in Vienna.20 Later, in August 1849 he 
became the society’s provisional director.21 However, in 
February 1851 the authorities concerned prohibited the 
activities of the society, and in November 1852 the 
Ministry of the Interior dismissed a petition in respect 
of this matter and confi rmed the prohibition of the so-
ciety’s ability to act.22
Despite his disappointment Ehrmann did not aban-
don his idea of establishing a pharmaceutical society. 
In 1855 his initiative to form a “Moravian Apothecary 
Society” (Mährischer Apothekerverein) in Olmütz – 
the town where he lectured at the university – was fi -
nally successful.23 Th e new society aimed to improve 
the apothecaries’ situation, and to provide fi nancial 
support to needy pharmacy students as well as to phar-
macists and their families in cases of illness, death and 
accidents.24 Th e humanitarian goals might have helped 
to secure the approval of the society.
Ehrmann did not lose sight of his goal to form a so-
ciety with a wider sphere of action. He was aware that 
reforms in pharmacy required a wider operating range. 
He succeeded in attracting pharmacists from various 
countries across the Austrian Empire and enlisted them 
as members of the Moravian Apothecary Society.
Th e General Austrian Apothecary Association, 1861
In 1858 the Moravian Apothecary Society installed a 
committee in Vienna to prepare the formation of an 
overall Austrian apothecary society.25 Th e ministry fi -
nally approved the statutes three years later, in 1861, 
and the new society – under the title “Th e General Aus-
trian Apothecary Association” (Allgemeiner Österrei-
chischer Apotheker-Verein) – was able to start its ac-
tivities with 266 members. In the same year the 
Moravian Apothecary Society dissolved itself and 
handed part of its assets to the new society. Ehrmann’s 
journal, the “Austrian Journal for Pharmacy” became 
the journal of the new society.26 In 1863 the journal 
changed its name to “Journal of the General Austrian 
Apothecary Association” (Zeitschrift des Allgemeinen 
Österreichischen Apotheker-Vereines).27
Pharmacists from all over the empire could enlist as 
members in this new society. Members included own-
ers of pharmacies as well as assistant pharmacists, if the 
latter held a degree as Magister of Pharmacy or Doctor 
of Pharmacy. Registered in Vienna, the society became 
the most powerful pharmaceutical society in the Aus-
trian Empire. Th e goals of the society comprised pro-
fessional reforms – mainly those of the pharmacy own-
ers – and the support of pharmaceutical sciences.
During its early years the society’s activities fo-
cussed on professional problems of the apothecaries, 
mainly on the concession system and the tariff  list, 
and on the inadequate education of the apprentices.28 
Th e society ran a library and built up a large collection 
of herbaria and plant drugs for teaching and scientifi c 
investigations. However, it largely neglected the inter-
ests of the assistant pharmacists during the following 
years.
Figure 4. Library of the Austrian Apothecary Association 
as portrayed in 1908.
Th e library located in the building of the Austrian 
Chamber of Pharmacists in Vienna still exhibits the orig-
inal bookshelves and the galleries of 1908.
(Source: Library, Austrian Chamber of Pharmacists, 
Vienna, Austria)
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Th e pharmaceutical school of the General Austrian 
Apothecary Association in Vienna, 1865
Th e instructions for the training of apothecaries, assis-
tant pharmacists and apprentices, as outlined in an Or-
der of 1834,29 did not oblige apprentices to attend phar-
maceutical lectures at the university. Th is order was a 
setback in the apprentices’ education, because earlier 
regulations had requested their attendance at those lec-
tures. Th erefore their knowledge depended greatly on 
that of the apothecary who was educating them and on 
self-study using recommended textbooks.
Th e health authorities still regarded pharmacy as a 
handicraft for which no scientifi c qualifi cations were 
required. However, the progress in natural sciences 
made during the course of the nineteenth century re-
quired a change in the apothecary’s education. As the 
production of chemicals had started to drift from phar-
macies to the rapidly developing chemical industry, 
new testing methods became necessary to guarantee the 
identity and quality of the purchased pharmaceuticals. 
Th erefore pharmacists needed to know more about 
chemistry and to learn new methods to identify the 
products and to scrutinize their quality and purity.
To cover this lack in education the General Austri-
an Apothecary Association founded a school in Vienna 
in 1865 to instruct apprentices. At fi rst courses were 
held during two semesters. Th e taught subjects includ-
ed theoretical chemistry, botany and pharmacognosy 
and practical exercises in the laboratory. Attendance 
was voluntary and free of charge; only a small fee had 
to be paid for the practical work in the laboratory. Th e 
curriculum was gradually enlarged up until the end of 
the nineteenth century, and included instruction in 
physics, analytical chemistry, pharmaceutical chemis-
try, practical pharmacy, legal knowledge and book-
keeping.
By 1905 the courses lasted 18 months and were 
compulsory for Viennese apprentices. Th e school fi nal-
ly closed in 1922 when a new curriculum was intro-
duced at the university.30, 31
Since then the pharmaceutical staff  of a pharmacy 
have needed to hold the university degree “Magister der 
Pharmazie” to be allowed to work as a pharmacist there. 
Practical training in the pharmacy had then to be car-
ried out after the university studies.32
In 1888 the General Austrian Apothecary Associa-
tion established laboratories equipped to examine edi-
ble products and to perform chemical, pharmacognos-
tic and medical analyses. In 1891 the society opened a 
laboratory for bacteriological analyses.33
Figure 5. Collection of herbal drugs at the clubhouse of 
the Austrian Apothecary Association in Vienna, 1910 
(Source: Library, Austrian Chamber of Pharmacists, Vi-
enna, Austria)
Figure 6. Th e building housing the laboratories of the 
Austrian Apothecary Association. In the background is the 
clubhouse of the society, late 19th century. (Source: Library, 
Austrian Chamber of Pharmacists, Vienna, Austria)
Th e society was active until 1938 when all Austrian 
pharmaceutical societies were disbanded. In 1946 the 
society registered again, representing only the pharma-
cy owners.34 It survives today, but since 1959 it has op-
erated under the name “Austrian Apothecary Associa-
tion” (Österreichischer Apotheker-Verband).35
Th e Pharmaceutical Assistants Society, 1868
During the nineteenth century the assistant pharma-
cists tried to improve their dismal situation by forming 
new societies to enforce their demands. Th e assistants 
missed out on professional representation by existing 
organisations since the apothecary board only repre-
sented the owners and supervising heads of pharmacies. 
Th e fi rst such body was the “Pharmaceutical Assis-
tants Society” (Pharmaceutischer Assistenten Verein). 
Its activities started with much enthusiasm in Vienna 
in 1868. However, only one year later the society de-
clined, because leading members left it to become 
apothecaries. Opposition to this society grew amongst 
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1901 the society called for a graduation ceremony for 
pharmacists similar to that marking the end of the doc-
tor’s training. A petition was submitted and was suc-
cessful.38
Th e annexation of Austria by the Th ird Reich in 
1938 stopped all activities by the Austrian Pharmaceu-
tical Society. However, the society was restored in 1980 
to pursue purely scientifi c goals. Since then it has sup-
ported pharmaceutical sciences in Austria and has reg-
ularly organised scientifi c congresses at universities in 
Vienna, Graz and Innsbruck.39
Th e General Austrian Assistant Pharmacists Society, 
1891
Towards the end of the century the professional situa-
tion of the assistant pharmacists had become entirely 
unsupportable. In consequence they formed another 
new society to raise their demands. In 1891 the fi rst 
general assembly of the “General Austrian Assistant 
Pharmacists Society” (Allgemeiner Österreichischer 
Apotheker-Assistenten-Verein) was held in Vienna.40 
Th e assistant pharmacists had very diffi  cult working 
conditions, low wages and long working hours. Th e 
main goals of the new society were to achieve profes-
sional reforms and to improve the working conditions 
of the assistants. Th ey demanded representation on the 
apothecary board, a change in the concession system, 
and the implementation of a retirement fund.
To give former members who had purchased phar-
macies in the meantime the possibility of joining the 
society, its name was changed in 1896 to the “General 
Austrian Pharmacists Society” (Allgemeiner Österrei-
chischer Pharmazeuten-Verein).41 Subsequently, other 
similar assistant pharmacists’ societies came into being 
in all parts of the Austro-Hungarian Monarchy.
Th e Association of Pharmaceutical Societies of Aus-
tria, 1898
To better achieve the realisation of their demands, sev-
eral of the assistant pharmacists’ societies of the empire 
united in 1898 to form a supra-regional association, the 
“Association of Pharmaceutical Societies of Austria” 
(Verband pharmazeutischer Vereine Österreichs).42 
Th ey realized that a strong association could put more 
pressure on the health authorities and pharmacy own-
ers in order to carry out reforms. Th e General Austrian 
Pharmacists Society had initiated that union, and very 
soon the majority of the empire’s assistant pharmacists 
societies joined in.
In 1910 the association changed its name to “Phar-
maceutical Federation of Austria” (Pharmazeutischer 
Reichsverband Österreichs).43 It operated until 1938 
when it was disbanded. In 1946 this federation 
the pharmacy owners because they feared that the ex-
isting concession system might undergo radical chang-
es. Many assistants left the society for fear of being dis-
missed from their jobs. In 1875 the society stopped its 
activities without ever being formally dissolved.36
Figure 7. Laboratory of the Austrian Apothecary Associa-
tion in Vienna, 1910 (Source: Library, Austrian Chamber 
of Pharmacists, Vienna, Austria)
Th e Austrian Pharmaceutical Society, 1873
During the nineteenth century numerous pharmacists 
were not content with the activities of the “General 
Austrian Apothecary Association” because the society 
focussed mainly on the school and the interests of the 
Viennese pharmacy owners.
In 1873 a new society was formed under the name 
“Austrian Pharmaceutical Society” (Österreichische 
Pharmazeutische Gesellschaft). Th is aimed to achieve 
the necessary reforms for the whole profession, empha-
sising the interests of the pharmacists in the diff erent 
Austrian territories of the monarchy. All Austrian phar-
macists of the Monarchy were contacted and invited to 
become members. Th e activities of the society embraced 
a wide range of issues including the concession system, 
changes in the salary system, the working out of drafts 
for an apothecary law, and proposals to improve phar-
maceutical education at the university. Some members 
collaborated with the Ministry of the Interior to work 
on the new edition of the Austrian pharmacopoeia, and 
were delegated to the meetings of the public health au-
thorities.37
From the very beginning the society was interested 
in advocating pharmaceutical sciences. Th e society sup-
ported reforms in the university curriculum, and in 
1897 campaigned for the admission of women to uni-
versity studies. By 1895 women had already been ad-
mitted to the study of pharmacy in Hungary, and fi -
nally in 1900 women could also enrol in pharmacy in 
all other parts of the Austro-Hungarian Monarchy. In 
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revived,44 and it has acted since then as a body repre-
senting the interests of employed pharmacists. In 2000 
the name was changed to the “Association of Employed 
Austrian Pharmacists” (Verband Angestellter Apothek-
er Österreichs, or VAAÖ).45
Th e Society of Sons of Apothecaries, 1904
As discussed earlier, the apothecaries and the assistant 
pharmacists tried to obtain reforms for the pharmaceu-
tical profession, but at fi rst they were not successful. In 
1870 a new pharmacy bill came into force, but this dis-
regarded the demands of the pharmacists. As a result of 
this omission from the health regulations the pharma-
cists demanded that a new pharmacy bill be published.
At the turn of the twentieth century heated debates 
fi nally pressured the health authorities to deal with the 
necessary reforms in pharmacy. Th e pharmaceutical so-
cieties – regardless of whether they supported the assis-
tant pharmacists or the pharmacy owner – put pressure 
on the authorities to regulate the pharmaceutical af-
fairs.
In 1904 a “Society of Sons of Apothecaries” (Ver-
einigung der Apothekersöhne Österreichs) was consti-
tuted to demand a change in the draft of the new phar-
macy bill.46 Th e bill foresaw that the pharmacy business 
of a deceased apothecary could not be carried on if his 
wife died after him and his full-age son still lacked the 
qualifi cations needed to run a pharmacy. As the require-
ments stated in the draft represented a considerable dis-
crimination against such individuals the society suc-
ceeded in its demands. Th e society was dissolved in 1907 
when a new law regulating the pharmaceutical aff airs 
was put into force.47 Th e Apothecary Law of 1907 at least 
implemented some important reforms needed in phar-
macy such as a new structure for the Apothecary Board, 
representing both owners and assistant pharmacists.
Pharmaceutical Welfare Societies 1838 to 1916
Another great problem for the assistant pharmacists was 
the lack of any kind of health insurance. During the 
nineteenth century various societies were formed dedi-
cated to the welfare and fi nancial support of the phar-
macies’ employees and their families. One such society 
was the “Supporting Institution of the Viennese Apoth-
ecary Board” (Unterstützungsverein des Wiener 
Apotheker-Hauptgremiums) founded in 1838.48 
Henceforth, the New Year’s gratuities, which were dis-
tributed by the Viennese apothecaries among physi-
cians and customers, would in future go into the wel-
fare fund of the society to support needy pharmacists 
and their families.
Another pharmaceutical welfare society started its 
activities in 1881 in Vienna; this was the “Apothecary-
supporting Institution Hygea” (Apotheker-Unterstüt-
zungs-Institut Hygea).49 In 1888 a new law introduced 
a compulsory health insurance scheme valid for all 
workers except public servants.50 As that bill also ap-
plied to pharmaceutical employees in pharmacies,51 the 
welfare society “Hygea” established the new health in-
surance fund “Hygieia” where the pharmaceutical per-
sonnel could register.52 Th e welfare society itself (in lit-
erature cited alternately as Hygea or Hygieia) remained 
active until 1920.53
In the following years more health insurance funds 
developed. In February 1913 a supra-regional health 
insurance fund for pharmacists (Krankenkasse der 
Apotheker Österreichs) was registered and extended its 
sphere of action to the Austrian territories of the Aus-
tro-Hungarian Monarchy.54, 55
A third remarkable society, the “Society of Green 
Cross” (Gesellschaft vom grünen Kreuz, Österreichi-
sches Pharmazeutenheim) was founded in 1908 to 
mark the Diamond Jubilee of Emperor Franz Josef I.56 
Th is charity organisation aimed to establish and rent 
buildings to run sanatoria, homes for convalescence 
and recreation for pharmacists and their family mem-
bers. Th e society organised well-attended charity events 
to collect generous donations for its activities. Unfor-
tunately the work of the society came to an abrupt end 
with the start of the First World War, and in 1916 the 
books, archive and remaining minor assets were trans-
ferred on an interim basis to the “General Salary Fund 
of Austrian Pharmacists” (Allgemeine Gehaltskasse der 
Apotheker Oesterreichs).57 However, the society was 
not revived after the war.
Pharmacy Pension Schemes 1894 to 1927
One important issue for older assistant pharmacists was 
the lack of a pension or retirement pay. Very late on, in 
1894, a pension fund for pharmacists (Pharmazeutisch-
es Pensionsinstitut für Österreich) was formed,58 but it 
was dissolved fourteen years later, in 1908.59 In 1906 
the government had passed a bill which implemented a 
compulsory retirement pension insurance for all em-
ployees, which became eff ective on 1 January 1909.60 
Consequently, pension funds had to be established. In 
1909 the Ministry of the Interior approved the forma-
tion of an ersatz institute for the “General Pension Fund 
for Austrian Pharmacists” (Allgemeines Pensionsinsti-
tut der österreichischen Pharmazeuten).61
However, it took some time – until 1914 – for the 
“General Pension Fund for Austrian Pharmacists” to be 
fully constituted. It fi nally started work on 1 May 
1914.62 In 1926 the Austrian parliament enacted a new 
bill regarding obligatory insurance for employees in 
cases of accidents, sickness, retirement and unemploy-
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ment.63 In accordance with this law the “Insurance In-
stitution for Pharmacists” (Versicherungsanstalt für 
Pharmazeuten) came into being in 1927, also incorpo-
rating the “General Pension Fund for Austrian Phar-
macists”. Th is new institution operated with the “Gen-
eral Salary Fund of Austrian Pharmacists” as part of an 
administrative collective.64
Th e General Salary Fund of Austrian Pharmacists, 
1908
Th e low wages of the assistant pharmacists was another 
topic for continuous discussion between the employees 
and pharmacy owners. In 1902 the pharmacy owners 
agreed to a new salary arrangement for the Viennese 
assistant pharmacists. Each apothecary paid his assis-
tant pharmacist a basic salary irrespective of his length 
of service. At the same time the pharmacy owners had 
to make a defi ned contribution for each assistant to a 
fund controlled by the Apothecary Board. Out of this 
fund the board disbursed a bounty payment to each 
pharmaceutical employee according to the length of his 
service. Hence, older assistant pharmacists no longer 
had to fear being dismissed due to their higher wages.
Th is new system proved to be eff ective, and in 1908 
a new society named the “General Salary Fund of Aus-
trian Pharmacists” (Allgemeine Gehaltskasse der 
Apotheker Österreichs) held its inaugural assembly in 
Vienna. Some 300 pharmacy owners and 700 assistant 
pharmacists from all over the Austro-Hungarian Mon-
archy had already joined the society.65 Th e membership 
was voluntary until 1919 when the Austrian National 
Assembly passed a bill which implemented legally the 
salary fund applicable to all Austrian pharmacists.66 
Th is excellent salary system has survived until today.
To date pharmacists employed in public pharmacies 
or hospital pharmacies are paid according to a salary 
system, which comprises eighteen levels and provides a 
promotion to the next higher salary level every two 
years. Th e employer pays a standardised amount to the 
Salary Fund irrespective of the employee’s salary level. 
Today the “Pharmaceutical Salary Fund of Austria” 
(Pharmazeutische Gehaltskasse für Österreich) exists 
as a public corporation registered in Vienna, which acts 
in co-operation with the Austrian Chamber of Phar-
macists.67
Conclusion
Since the lifting of the ban on the formation of socie-
ties in 1849 numerous pharmaceutical societies have 
arisen in Austria. By the end of the Austro-Hungarian 
Monarchy era, which ceased in 1918, around forty 
pharmaceutical societies in the German language ex-
isted. As indicated in this review, four of them are still 
relevant for Austrian pharmacy today: the “Pharmaceu-
tical Salary Fund of Austria”, the “Austrian Apothecary 
Association”, the “Association of Employed Austrian 
Pharmacists” and the “Austrian Pharmaceutical Soci-
ety”.
Apart from the German speaking pharmaceutical 
societies, numerous national pharmaceutical societies 
existed in the diff erent territories of the Monarchy us-
ing their own mother tongue for communication. Such 
societies are known from Bohemia, Moravia, Galicia, 
Bukovina, Hungary, Croatia, Istria, Trentino and the 
city of Trieste.68
Many pharmaceutical societies did not focus solely 
on professional and educational reforms but also en-
gaged in sporting activities, entertainment or students 
aff airs. According to the research carried out in Austria 
to date the number of pharmaceutical societies reached 
around one hundred in the whole of the Austro-Hun-
garian Monarchy. Th ere may have been even more 
which have still to be discovered.
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A R T I C L E
A gift of scented oils to Oliver Cromwell 
from the Grand Duke of Tuscany in 1657?
Andrew Hardy
Abstract
Further studies have been done on two samples from 
the middle drawer of an Italian seventeenth century 
chest or cabinet. Some newly acquired historical and 
observational information has been combined with a 
re-interpretation of previously collected chemical ana-
lytical data. Th e results strongly indicate that the orig-
inal samples were scented oils, and that the carrier oil 
used was very probably moringa oil. Th e absorbed 
scents were likely to have been jasmine or orange ex-
tracts. Th ere is evidence to suggest that the chest was 
sent as one of several gifts from the Grand Duke of Tus-
cany to Oliver Cromwell in 1657.
A brief history of scented oils
A scented oil is here defi ned as a carrier (sometimes base 
or plain) oil, of little or no odour, to which has been 
added some sweet-smelling extract from a plant or an-
imal. Th is extract consists of molecules with distinctive 
odours and which are usually volatile, and where the 
fi nal scented oil is when they have been absorbed into 
a stable carrier oil by maceration or enfl eurage.1
We are surrounded by scents and have been for mil-
lenia. In the past our lives could depend on being able 
to recognize specifi c animal scents (bear or deer?), and 
being able to distinguish between good ones (freshly 
cooked food for example) and bad ones (for example, 
rotten food). Finding a naturally scented material, such 
as a tree exudate, and then using it to scent clothes and 
bedding must have occurred. Th e knowledge of the 
makings and uses of scented materials is generally con-
sidered to have originated in the Near East of Mesopo-
tamia in the late fourth millennium BCE. Th is knowl-
edge was used, adapted and improved upon by the 
various civilisations of Mesopotamia. Th ese were, in 
approximately chronological if overlapping order: 
Sumerian, Akkadian, Babylonian and Assyrian. Babylon 
fi nally fell to the Achaemenid (Persian) Empire in the 
sixth century BCE, which in turn fell to Alexander the 
Great in c.330 BCE. Using the trade routes of these civ-
ilisations the knowledge spread west to the Levant (Pal-
estine and Lebanon) and on into the Mediterranean.2
It intermingled there with local knowledge and 
again was improved upon by the peoples it encoun-
tered. Th ese were, from the late fourth millennium 
BCE to the late fi fth century AD: Ancient Egypt (based 
along the Nile), Minoan (centred on Crete), Mycenaean 
(centred on mainland Greece), Classical and Hellenistic 
Greece and on to the Roman Republic and Empire. Af-
ter Rome fell and Europe entered its Dark Ages and 
Medieval Period (c. 500 AD to c. 1500 AD overall) at 
least some of this accumulated knowledge on scented 
materials was retained in the libraries of the European 
monasteries and by the Byzantium Empire (based at 
Constantinople, and which fell to the Ottoman Turks 
in c.1450 AD). Also, and most importantly, it was ex-
panded and improved upon and written down by the 
Arab scholars of the emerging Islamic Empire. 3, 4, 5, 6
By the sixteenth and seventeenth centuries this new 
knowledge was largely available in written form and the 
‘still-room’ had moved out from the monasteries to 
most of the Palaces and grand houses of Europe. Th ere 
herbs were dried, spices stored and a simple form of dis-
tillation done. Th is latter occupation was labour inten-
sive, diffi  cult and sometimes gave low yields. Th us es-
sential oils could sometimes be made by distillation, but 
the main methods used to make scented oils/fats/wax-
es were still enfl eurage and maceration.7, 8, 9
However, by the nineteenth century in Europe 
much more effi  cient (steam) distillation was increas-
ingly replacing these older absorption techniques. Th e 
essential oils so made could then be directly added to 
the carrier material. Distillation in turn was increas-
ingly replaced by solvent extraction in the twentieth 
century, so that now the older techniques of enfl eurage 
and maceration are no longer used commercially. Also, 
synthetic organic chemistry had improved suffi  ciently 
to be able to make some synthetic aroma molecules by 
the early twentieth century. Around 1900 almost all 
fragrance ingredients were natural; by 2000 about 90% 
were synthetic. As Ernest Beaux (1881-1961), creator of 
Chanel No. 5, famously stated: “Th e future of perfum-
ery is now in the hands of the chemists”.10, 11
Carrier oils and uses of scented oils
Th e fi rst carrier oil used, as mentioned in the texts of 
the earliest civilisations of Mesopotamia, is thought to 
have been sesame oil.12  Th e oils most used in the later 
Mesopotamian, Egyptian, Minoan and Mycenaean 
civilisations were: balanos, moringa, sesame, almond, 
castor and later (from c.1350 BCE grown in Egypt, and 
probably imported earlier from the Levant) olive oil.13, 
14, 15  Olive oil was often used in the later Greco-Roman 
period, and in the De Materia Medica of Dioscorides 
(c.40-90 AD) the oils to be used as bases in scented oils 
were given as: olive, sesame, moringa and (sweet) al-
mond oils.16, 17 Olive oil was, and still is, usually read-
ily available at reasonable cost and so was/is often used. 
Now, in addition to some of the above oils there are 
other oils available to be used as carriers. Th ese include 
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apricot, avocado, coconut, grape, jojoba, peach and 
sunfl ower oils.18
An enormous array of aroma molecules has been 
extracted over time from animals (for example: civet, 
musk, ambergris) and various plant parts (for example: 
myrrh, cinnamon, lavender, rose, orange, jasmine). 
Now, the chemical laboratories of the present-day per-
fume industry are making a multitude of new scent 
molecules every year.19, 20
Scented oils have had a variety of uses over the last 
fi ve millennia. In general terms these are: medicinal, 
cosmetic, ritual and some unusual uses. In medicine 
they have been, and sometimes still are, used for topi-
cal application to the skin to treat bruises and burns, to 
aid in massage and as a general emollient.  Th ey were 
also taken internally in small doses as a mild laxative 
and as a perceived cure for stomach and kidney prob-
lems and as a plague preventative. Cosmetic uses have 
been: applied to gloves, shirts, bedding as well as the 
skin and hair to improve odour; and wearing or burn-
ing a strong scent to ward off  the plague and to cover 
the stench of decay. Ritual uses have included anoint-
ing the living, the dead and the temple statues of the 
Gods or ancestors; and burning it in the temple to in-
duce a relaxing atmosphere for prayer and meditation. 
Some unusual (possibly ritual) uses have been: founda-
tion deposits of containers of oils/fats in the base layers 
of some of the oldest buildings excavated in Mesopota-
mia; and similarly scented oils were known to have been 
mixed with the mortar used for the foundation stones 
of mosques of the later Islamic Empire.21, 22, 23, 24
Recent studies have shown that some scents have 
antimicrobial, insecticidal and bactericidal properties. 
Chemists are looking at such scents to try to identify 
and isolate the biologically active molecules.25 Specifi c 
uses relevant to my results will be mentioned in the dis-
cussion section below.
Examples of published analyses of old residues
Samples that probably originally contained scented oils 
and which were used for medicinal and/or cosmetic 
purposes by the living, and whose surviving residues 
have been chemically analysed by modern spectroscop-
ic methods and the results published, are few. Brief 
summaries of three such examples are given below.
Example 1:  Residues from the interiors of three 
Base Ring I juglets were analysed using the GC-MS 
(Gas Chromatography- Mass Spectrometry) technique. 
Th e juglets were excavated at Tel Beth-Shemesh (about 
25 kilometres west of Jerusalem in Israel), and dated to 
the fourteenth century BCE. From their analytical data 
the authors inferred the presence of an oil in each ju-
glet, which could not be identifi ed. Additionally they 
found evidence that mint was infused in the oil of one 
residue, and for another residue they found a degrada-
tion compound which was suggestive of a medicinal 
(scented) oil. Th e oils were thought to have been used 
for either medicinal or ritual anointing purposes.26
Example 2: Two Roman-era pink make-up and/or 
rouge samples were studied by a variety of analytical 
techniques. Both samples were found in the excavated 
Roman colony of Celsa (Zaragoza, Spain). Madder lake 
was the pigment used to give the pink colour in both 
samples, but made by precipitation on two diff erent 
aluminium compounds and each then absorbed by two 
diff erent base materials – inorganic for one sample and 
organic for the second sample. Th e second sample, from 
the surface of a cosmetic stirring tool that was dated to 
about the fi fth century AD, was analysed using various 
Mass Spectrometry (MS) related techniques. A vegeta-
ble oil (possibly olive oil), mixed with a small amount 
of animal fat, was indicated. Th e authors state that this 
oil had been scented before being used for this make-
up and/or rouge, but the scent’s identity could not be 
conclusively determined.27
Example 3: In a very recent publication some Red 
Lustrous Wheelmade ware sherds (where approximate-
ly 60% of the sherds were found to contain usable ab-
sorbed organic residues), and three visible residues, were 
analysed by the GC-MS technique. Th ey were obtained 
from various sites in Turkey, Cyprus, Egypt and Syria 
and dated to the eastern Mediterranean Late Bronze 
Age (c.1600-1000 BCE). Twenty-two sherds and the 
three visible residues contained only one commodity, 
(probably) plant oil. It could not be identifi ed, but one 
of these sherds and all of the visible residues were also 
found to contain small amounts of castor oil. Another 
twelve sherds were found to contain two commodities, 
namely plant oil mixed with beeswax (seven sherds) or 
bitumen (fi ve sherds). Th e absorbed residues of the re-
maining sherds each contained one commodity – bees-
wax (in sixteen sherds), bitumen (in six sherds) or pine 
resin (in three sherds).
It was thought that at least some of the original ves-
sels made of this ware at this time contained scented 
oil, but no chemical evidence was found to identify any 
scent material so used. A variety of uses were suggested 
for both the containers and their contents. Th e con-
tainer jars were used for transport and storage of liq-
uids, which were then probably used for libation pour-
ing in a domestic, ritual or tomb environment. Th e 
identifi ed residues could have been used medicinally 
(the castor oil) or as cosmetics (the scented oils).28
As can be seen from the above examples there is 
sometimes a degree of uncertainty regarding the detec-
tion of even the presence of a plant oil in an old or de-
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graded residue. Identifi cation of the plant oil is rare, but 
is possible for oils that have distinctive ‘molecular bio-
markers’ that can survive the centuries (as for castor oil 
above). An example where several old samples, from the 
same excavated site, have been analysed and evidence 
found for the presence of scent, but having beeswax as 
the scent carrier, is given below.
Residues from seven Roman glass unguentaria were 
analysed using various combinations of gas chromato-
graphic and mass spectrometric techniques. Th e unguen-
taria were found during an excavation of a Roman villa 
in the ancient town of Oplontis (today this is Torre An-
nunziata, about 20 kilometres south east of Naples, Ita-
ly). Th e unguentaria were dated to between the fi rst cen-
tury BC and the fi rst century AD. Beeswax, pine resin 
and another waxy-lipid material of plant origin were 
identifi ed in all of the residues. Th e presence of the waxy-
lipid plant material was said to show that the original 
material had been scented using maceration or enfl eur-
age, possibly using plant fl owers and/or leaves. Th e au-
thors suggested that these contents indicated that they 
were originally made as (scented) cosmetics (for example: 
moisturising face creams) or as (emollient) skin balms.29
(1599-1658; Figure 1), Lord Protector of England (1653-
1658).30 One of these gifts is reputed to be the stone in-
laid Florentine cabinet and its contents (Figure 2) cur-
rently on display in the Oliver Cromwell museum in 
Huntingdon in Cambridgeshire, UK. Th e cabinet’s di-
mensions are 41cm wide by 36cm deep and 29.5cm 
high. Th e cabinet has been independently inspected by 
furniture historians and assessed to be a Florentine pi-
etra dura (literally: hard stone) cabinet made in the pe-
riod 1653-1658.31 Th e contents of the cabinet’s small 
tubs/pots, where some of the empty pots can be seen in 
the foreground of Figure 2, are believed to have been 
made up by the “L’offi  cina Farmaceutica di Santa Maria 
Novella” in Florence prior to the cabinet being sent to 
England.32
Figure 1. Oliver Cromwell, Lord Protector of England, 
1599-1658. (Source: © Cromwell Museum, Huntingdon, 
UK)
Th e samples studied and their provenance
Th ere is evidence that in 1657 the Grand Duke of Tus-
cany, Ferdinando II de’ Medici (1610-1670 and who 
ruled 1621-1670), sent various gifts to Oliver Cromwell 
Figure 2. Th e Florentine cabinet and some containers. 
(Source: © Cromwell Museum, Huntingdon, UK)
Th e contents of the cabinet’s tubs or pots were all 
removed and placed in modern air-tight glass contain-
ers approximately forty years ago. Samples from the top 
drawer of the cabinet were found to be soft soaps, as 
reported in a previous article.33 Small amounts of solid 
were also removed from two containers whose contents 
had originally come from the cabinet’s middle drawer 
(hereafter MD). Figure 3 shows a side-view of four of 
the original glass containers.
Th ese two samples (labelled MD 16/55 here, where 
MD 5 in Figure 3 corresponds to my MD 55) were pre-
viously chemically analysed and these initial results in-
https://doi.org/10.24355/dbbs.084-202007291249-0
 PHARMACEUTICAL HISTORIAN  ·  2018  ·  Volume 48/3 71
terpreted to indicate that both samples contained, in 
varying amounts, a soap (sodium palmitate), beeswax 
and/or possibly some plant wax, and ruminant adipose 
fat and/or cocoa butter.34 Th e samples were originally 
thought to be skin balms, but are now thought more 
likely to have been scented oils.
I present here some new historical and observation-
al information combined with a re-interpretation of the 
previously collected chemical analytical data on these 
two solid samples. Also briefl y mentioned later is some 
relevant qualitative results from more recently collected 
Gas Chromatography – Mass Spectroscopy (GC-MS)35 
data, but which is not yet fully interpreted. A paper 
containing this new data will be published later. In this 
paper it is hoped to also include additional analytical 
data, including that obtained by Fourier Transform In-
frared spectroscopy (FTIR) and Gas Chromatography-
Combustion-Isotope Ratio Mass Spectroscopy (GC-C-
IRMS).36
Chemical analytical methods and results
Th e technique of Fatty Acid Methyl Ester derivatisation 
on methanol extracted material (FAME GC-MS) was 
previously done on both the MD samples.37 Th ese re-
sults are summarized below, with some additional in-
formation given in an Endnote.38
A) MD16 sample. Nine of the eighteen compounds 
identifi ed were saturated straight-chain carboxylic acids 
(C8/9/10/16/18/20/21/22/24, to a total presence of al-
most 79%). Th e fi ve acids having the highest percent-
ages were: C16:0 (24.3%), C22:0 (18.6%), C18:0 
(16.5%), C20:0 (12.0%) and C24:0 (3.3%). Addition-
ally there were: four dicarboxylic acids (2C7:0 to 
2C10:0, where the ‘2’ signifi es the presence of two car-
boxylic groups per molecule, and present to a total of 
10.4% and where 2C9:0 (Azelaic acid) had the largest 
amount present – at 4.7%); two C18:2 isomers (to a to-
tal of 3.7%); one oxo- and one dihydroxy- derivative of 
C18:0 (at 0.5% and 3.8% respectively); a small amount 
of C18:1 (oleic acid, at 3.4%) and a just detectable small 
amount of C17:0 (estimated to be about 0.2%).
B) MD55 sample. Twelve of the twenty-fi ve com-
pounds identifi ed were saturated straight-chain carbox-
ylic acids (C7/8/9/10/16/17/18/20/21/22/23/24, to a to-
tal of almost 74%). Th e four acids with greater than 
10% percentages were: C16:0 (20.3%), C18:0 (18.7%), 
C22:0 (16.3%) and C20:0 (12.0%). Also present were: 
six dicarboxylic acids (2C6:0 to 2C11:0, to a total of 
13.8% and where 2C9:0 had the largest amount pre-
sent, at 5.8%); two C18:2 isomers (to a total of 6.3%); 
one oxo- and one dihydroxy- derivative of C18:0 (at 
0.7% and 1.8% respectively) and one oxo- derivative of 
C9:0 (at 0.3%); some C18:1 (at 3.0%) and a very small 
amount of phthalic acid (at 0.2%), where this last com-
pound is the acid derivative of the plasticiser diethyl 
phthalate (assumed to be from its most recent contain-
er). Th e amounts of C17:0 and C24:0 found were 0.4% 
and 2.0% respectively.
A re-interpretation of the above FAME GC-MS re-
sults will be presented in the discussion section below.
Figure 3. Side-view of four middle drawer containers. 
(Source: © Cromwell Museum, Huntingdon, UK)
New historical and observational data and its inter-
pretation
Before I consider the re-interpretation of the analytical 
chemistry data given above I will fi rst present other in-
formation that can aid me in identifying the original 
contents of the second, middle drawer of this chest.
First I will consider the chest itself. It has been var-
iously described, one such description being “cassette 
per profumi” (box of perfumes/scents).39 Its top and 
bottom drawers contained soft soaps and ointments re-
spectively. At least some, and possibly all, of these were 
scented (jasmine and orange extracts having been iden-
tifi ed).40 Th us scented oils could be possible candidates 
for the original contents of the middle drawer. Th is sug-
gestion is supported by the shape of the glass containers 
in this middle drawer. Th ey have a narrow base which 
widens out and then reduces to a narrow short neck and 
a small (corked) top (see Figure 3). Th e containers from 
the other two drawers do not have narrow necks but do 
have much wider open tops (see the foreground of Fig-
ure 2). Th ey contained soft solids, whereas a narrow 
neck implies a liquid content, such as a scented oil.
Secondly I will consider the physical state now of 
the remaining contents of the second drawer samples. 
Th ese samples are currently stored in small boro-silicate 
glass bottles. Th ey are now each a mixture of a signifi -
cant amount of light yellow soft solid and a darker oil. 
Non-drying oils, such as almond and olive oils, are 
known to thicken and partially precipitate as they age.41 
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A non-drying oil was usually used in the past as the car-
rier oil for the production of scented oils.
So, which carrier oils were being used in seven-
teenth century Europe? Th e De Materia Medica of Di-
oscorides 42, 43 was probably still being used, albeit en-
larged and modifi ed. A study of various recipe books of 
the seventeenth and early eighteenth centuries reveals 
the use of three of the four carrier oils given by Diosco-
rides. Th ese are moringa (sometimes known as ben or 
behen) oil, olive oil and (often sweet) almond oil (the 
fourth being – from Dioscorides – sesame oil).44, 45, 46
Some of these listed recipes and uses will be men-
tioned later, where they are relevant to my results. Also 
melting points of these fresh oils should be mentioned. 
Olive, almond and sesame oils all have melting points 
below 0° C, whereas moringa oil has a melting point of 
about 19° C. Th us moringa oil, after several centuries 
of ageing, would perhaps be the most likely to signifi -
cantly precipitate at museum room temperature, as 
found for my samples?
Discussion of the chemical data
I will now discuss the re-interpretation, especially in the 
light of the above information and its interpretations, 
of the FAME GC-MS data listed in the results section. 
Fatty acid ratios are commonly used to indicate if a fat 
or oil is present in an old residue.47, 48 Th e most com-
monly used is the Palmitic acid (P, C16:0) to Stearic 
acid (S, C18:0) ratio. My P/S ratio values are 1.5 and 
1.1 for the samples MD 16 and MD 55 respectively. 
Th ese values are in the range that usually indicates the 
presence of an animal fat.49
But given the previous information and associated 
interpretations are there any known carrier oils of the 
past with a P/S ratio in the range 1.0 to 1.5? Of the three 
carrier oils mentioned above only one is in this range 
– Moringa oleifera oil (the most common species from 
which this oil was obtained). Th e P/S ratio range found 
in the recent literature for this species is 1.0 to 1.6. Oth-
er species of this oil also fall in this range (for example, 
Moringa peregrina oil, which was and still is grown in 
Egypt), and a few that do not (for example, Moringa 
concanensis oil, which has a reported P/S value of 
3.1).50, 51  Olive and almond oils have (the expected) sig-
nifi cantly higher P/S values.52
All the above three carrier oils are non-drying oils; 
but can we show that our samples are non-drying oils? 
Such an oil is one which does not harden over time 
when exposed to air and light. Semi-drying oils harden 
slowly and often only partially. Drying oils harden 
completely, often over a relative short time. Hardening 
takes place via cross-linking polymerization, after oxi-
dation of the carbon to carbon double bonds found in 
the molecules (esters and free fatty acids) present in the 
oils.53
Also in oils there is the formation of dicarboxylic 
acids over time, via oxidative cleavage at the same dou-
ble bond(s) and the subsequent formation of a second 
carboxylate group (–COOH) in the new smaller mol-
ecule. Th e most commonly formed such acid is Azelaic 
acid (A, 2C9:0); this is found in decreasing amounts 
going from drying to semi-drying to non-drying oils. 
Th e associated A/P ratios usually found are: for drying 
oils ≥ 1, semi-drying oils < 1 and non-drying oils << 1 
(usually < 0.3). Also the ∑ % of dicarboxylic acids is 
found to be low for non-drying oils (< 15%) and high-
er for semi-drying (> 20%) and drying (> 40%) 
oils.54, 55, 56  Th e A/P and ∑ % values for my two samples 
(MD16/55) are 0.19/0.29 and 10.4%/13.8% respective-
ly. Th ese values show that the oils in the two samples 
are non-drying ones.
All the species of Moringa oil have relatively large 
amounts of C20:0 (arachidic acid), C22:0 (B, behenic 
acid) and C24:0 (lignocerinic acid) present (either as 
free acids, or as a component of esters that can hydro-
lyse over time to give the acids). Th e P/B ratio has a 
range of values for the Moringa oleifera oil, which is 
given in the recent literature as 0.9 to 2.3. Also, the fat-
ty acid profi le (regarding percentage presences of the 
fatty acids) for this oil is P ≈ S ≈ B and where C22:0 > 
C20:0 > C24:0.57, 58  Th e P/B value for both of my sam-
ples is 1.3, and they do have the above fatty acid profi le 
(see Results section).
Th us, using all the historical, observational and 
chemical data available, it can be shown that my two 
samples were originally scented oils. Th e carrier oil used 
is strongly indicated to have been Moringa oleifera oil. 
Whilst I have no defi nitive current chemical evidence 
for the identity of the scents present, I feel other data 
(on samples from the two other drawers of the chest59) 
indicate that jasmine or orange extracts were probably 
used to scent these oils. Also, initial qualitative inter-
pretation of the very recently collected GC-MS data 
shows no evidence for the presence of waxes or resins, 
only for the presence of a degraded fat or oil. Once ful-
ly processed and interpreted this data will be published 
later, hopefully combined with additional data (such as 
from GC-C-IRMS).
Past uses of moringa oil
Moringa oil has been known and used for millenia; its 
minimal odour, good absorbance of aroma molecules 
and its high resistance to becoming rancid made it an 
ideal carrier/base oil for scented oils/ointments/unguents.
It was imported into ancient Egypt of the Old King-
dom (from Syria and Cyprus) and later (perhaps from 
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the New Kingdom period) grown in desert areas (such 
as around Th ebes). It was used as a (hair) pomade, a 
skin emollient, a cooking oil, a cosmetic (scented oils/
ointments) and as a an externally applied medicine – all 
on/for the living.60
Two well appreciated scented oils of Roman usage 
were Susinum and Crocinum. Th e former was made 
from oil of moringa, roses, cinnamon, saff ron, myrrh 
and lilies, and was very popular as an ‘aftershave balm’. 
Th e latter was mostly oil of ben and saff ron, but because 
of the amount of saff ron used it tended to stain when 
in contact with clothing.61
Much later, in an early seventeenth century English 
recipe book,62 details are given of the somewhat lengthy 
process of scenting leather gloves. Th e carrier oil used 
in making the scented material, which was repeatedly 
applied to the gloves, was oil of ben or sweet almond 
oil (mixed with a little gum dragagant, also known as 
gum tragacanth and which is a gummy exudation from 
some species of Astragalus) and where the scents were 
extracts of rose, lemon or orange. Such gloves were pop-
ular with Elizabeth I, Charles I and even Oliver Crom-
well, who had such gloves which he used when riding.63
A later seventeenth century perfume recipe book 
(translated from its original French)64  gives details on 
the making of scented oils (‘essence of fl owers’) using 
oil of ben and extracts of jasmine or orange-fl owers.
Modern day uses of Moringa oleifera oil, seeds and 
leaves range from a potential food resource for humans 
and animals to a bio-diesel fuel to medical benefi ts for 
human health. Cosmetic use, to make long-lasting 
scented oils and ointments, is still being done albeit on 
a relatively small scale. It can also be used as a lubricant 
for fi ne machinery (for example: non-digital watches), 
and the seeds are currently used for water purifi cation 
in developing countries as an alternative to western 
methods. Medicinal use is currently largely confi ned to 
folk medicine; such as using the raw or crushed seeds 
as a decoction for treating stomach pain, ulcers, poor 
vision, joint pain and for aiding digestion. Other me-
dicinal properties have been suggested, but further 
pharmacological studies are needed to determine if they 
are valid.65
Only one example of a chemical analysis of an old 
ointment that (probably) contained moringa oil has 
been found in the English-language scientifi c literature. 
Th e sample was found in an Etruscan tomb in Chiusi 
(Tuscany, Italy) and dated to between 150/125 and 100 
BCE. Chemical analysis found evidence for a vegetable 
oil (thought to be Moringa oil from the fatty acid pro-
fi le) mixed with two plant resins (mastic and pine). Th e 
use of the ointment could have been cosmetic or me-
dicinal, though as the sample’s (alabaster) container was 
found in a cosmetic case (scrinium) then the former use 
is perhaps more likely.66
A recently discovered recipe for making scented oils 
from moringa oil and extracts of jasmine or orange 
fl owers, from a book published in Venice in 1682 (orig-
inally published earlier in French), gives a recipe whose 
translation is:
You will infuse the fl owers in Ben oil, sweet almond 
oil, or the four cold seeds oil, dipped without fi re in 
a glass vase, so that four of those fl owers fl oat on top 
of the oil. Cork your vase, and make [place?] the in-
fusion in the sun or in a lukewarm bath, for three or 
four days, then you will fi lter and express [squeeze] 
your oil from the bulk of the fl owers, replacing them 
with new fl owers, in the same way, and will repeat 
[the process] several times until your oil is well scent-
ed which will be the third or fourth time you place 
it in the sun.67
Th ere are two oils said to be of “the four cold seeds” 
(both obtained by cold pressing): oil from the four ma-
jor cold seeds – cucumber, melon, pumpkin and water-
melon; and oil from the four minor cold seeds – endive, 
lettuce, common purslane and chicory.
Conclusion
Th e two seventeenth century samples from the middle 
drawer of a “cassette per profumi” (box of perfumes/
scents) have been shown to have originally been scented 
oils. Moringa oil (oleifera species is/was the most com-
mon, but the Egyptian peregrina species is also a pos-
sibility) was very probably the carrier oil, and the scents 
most likely extracts of jasmine or orange. Additional 
analytical chemistry data, hopefully to be published in 
the near future, should give extra information on the 
scents used and will likely make the identity of the oil 
a certainty.
Th e results obtained here highlight the potential 
uncertainty of using indications to identify a fat or oil, 
based on fatty acid ratios and their assigned ranges. 
Th ey also show the advantages of combining historical, 
observational (of chest, containers and contents) and 
chemical data to give an exception to the usual indica-
tions. Additionally, a distinctive fatty acid profi le great-
ly helped in determining which oil was present. Th e 
combination of data fi ts only one oil, Moringa oil. As 
far as I am aware no other vegetable oil, past or present, 
fi ts all my data.
Sometimes data, from sources historical or chemi-
cal, can give interpretations and generate facts that are 
preliminary and which will be later re-interpreted. Such 
facts can thus slip in and out of the shadows of history. 
https://doi.org/10.24355/dbbs.084-202007291249-0
74 PHARMACEUTICAL HISTORIAN  ·  2018  ·  Volume 48/3
It is to be hoped that some light has been shone on the 
characterisation of these samples. However, further 
studies may be needed to remove all the shadows.
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S H O R T  C O M M U N I C A T I O N
Henry Humphreys (1867-1943): a 




Henry Humphreys was born in Hong Kong and qual-
ifi ed as a pharmacist in Britain. He was groomed to be-
come head of A. S. Watson, the leading chemist and 
druggist chain in China and the Philippines in the late 
nineteenth and early twentieth centuries. He was an 
entrepreneur, and grew the pharmacy business as a 
franchise to become a 100-outlet chain within 20 years. 
Watson’s produced their own range of patent medi-
cines, one of which “Anthelmintic Bonbons” became 
the patent medicine of choice among households 
throughout the far east, until its production ceased in 
1987. Th is article traces Humphreys’ life and career 















British colonial rule in Hong Kong began on 26 Janu-
ary1841 when the Union Jack was raised during the 
First Opium War. Th e cession was formally ratifi ed on 
29 August 1842 in the Treaty of Nanking, which ced-
ed Hong Kong to Britain “in perpetuity”. Fifty years 
later Hong Kong continued to serve not only the Chi-
nese mainland but also the rest of the world as an en-
trepôt with which goods, people, and services could 
move freely across the territory. With a burgeoning 
population of 220,000 in 1891 – including 10,000 Brit-
ish expatriates and their family members – Hong Kong 
had transformed itself from a small speck in the South 
China Sea to a town with vibrant business activities.
A young man by the name of Henry Humphreys 
returned to Hong Kong in 1889 at the age of 22 after 
gaining the pharmaceutical chemist qualifi cation from 
the Pharmaceutical Society of Great Britain. He joined 
Figure 1. Record of Henry Humphreys’ registration as a 
pharmacist 1889 (Source: 1919 Register of Pharmaceuti-
cal Chemists, PSGB)
his family business as the manager of A.S. Watson’s, a 
chemists and druggists business (Figure 1). Th e shop 
had been taken over ten years earlier by his father, John 
David Humphreys.
Humphreys grew the A.S. Watson business to a 
multi-national pharmacy chain throughout China and 
the Philippines over a period of 56 years, with periodic 
ups and downs. During this time, the company em-
ployed many British qualifi ed chemists and druggists 
to provide a similar quality of healthcare in the Far East 
as in Great Britain. However, in the midst of econom-
ic depression in 1933 – when Humphreys was 66 years 
of age – he decided to retire, and he departed Hong 
Kong for Vancouver Island, British Columbia.
Early childhood and acquisition of the A. S. Watson 
business 
Henry Humphreys was the eldest son of John David 
Humphreys, and was born in Hong Kong in 1867 when 
his father moved from Australia to Hong Kong to be-
come a bookkeeper for A.S. Watson. In the following 
year the then owner of A. S. Watson left, and John Da-
vid Humphreys and Arthur Hunt took charge of the 
business as partners. Henry grew up when the A. S. 
Watson business began to take off  after his father ac-
quired Arthur Hunt’s shares in the business in 1871, 
when Henry was 4 years of age. His father also estab-
lished his own company, subsequently known as John 
D. Humphreys & Son Ltd.
Watson’s dispensary business in Shanghai was man-
aged by S. W. Cleave, and traded as the Hong Kong 
Dispensary at 16 Nanking (now Nanjing) Road near 
the Bund from 1860. After the acquisition Humphreys’ 
father expanded Watson’s manufacturing capacity by 
opening a new factory in 1875 in the Central District, 
Hong Kong Island to produce fl avoured soda water and 
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other patent medicines. Th ese included the most well-
known over-the-counter medicine “Watson’s Anthel-
mintic Bonbons” which were sold throughout China.1 
Th e Watson brand became a well-known household 
name from that time.
Watson’s also began expanding beyond Hong 
Kong; its fi rst overseas branch opened in Manila in the 
Philippines in 1883. Watson’s then stepped up its pres-
ence in the Chinese mainland in more cities in addition 
to Canton and Shanghai. A. S. Watson & Co. Ltd. was 
eventually incorporated as a company in 1886.
With his childhood spent predominantly in a dispen-
sary business owned by his family, Henry Humphreys was 
groomed to become a successor for the family business. 
Subsequently, he was sent to study at St. Helen’s College 
in Southsea, England to prepare him for entry to the phar-
maceutical profession. Humphreys passed the major ex-
amination in London, and obtained his Certifi cate of Reg-
istration as a Pharmaceutical Chemist in 1889.2
Humphreys’ pharmacy career and commercial inter-
ests 
In 1889 Humphreys returned to Hong Kong where he 
subsequently joined his father’s business and became 
the pharmacist manager at Watson’s. He was one of 
three pharmaceutical chemists at the time, the other 
two being William Edward Crow, who was the Gov-
ernment Apothecary cum Analyst, and Frank Browne, 
who was the Government Assistant Apothecary.
Humphreys published an article on ‘Chinese Cin-
namon’ on the diff erentiation between Chinese cinna-
mon and cassia by visual and also chemical identifi ca-
tion methods, in the October 1890 edition of the 
American Journal of Pharmacy. In his article he de-
scribes how:
A cold aqueous infusion of all six samples yielded 
with iodine a bluish-black coloration, but with 
HgCl2 [mercuric chloride] there was no yield of the 
presence of mucilage. Th e aroma of all six came near 
that of Ceylon cinnamon, but in some cases there 
was a pungency more consistent with the idea of 
their being derived from cassia. One important 
point, however, I have been able to ascertain is, that 
Chinese Cinnamon grows wild in Annam much fur-
ther south than the West River in the Kwangsi and 
Kwangtung provinces, where cassia is cultivated. 1
Th is was an apparent exercise to establish his position 
as a qualifi ed pharmacist in the colony with knowledge 
of native Chinese herbs. A couple of years earlier, Wil-
liam Crow and others had similarly demonstrated their 
knowledge of Chinese herbs by publishing an article 
entitled ‘Notes on Chinese materia medica’ in Th e Chi-
na Review. 2 Th e Watson business grew very quickly and 
had become an exemplar for modern pharmacy in Asia. 
Figure 2. Alexandra Building in Central and Watson & 
Co. Chemists, 1910’s (Source: photograph supplied by A. 
S. Watson Group)
Th e business premises of A. S. Watson at this time (Fig-
ure 2) were described as follows:
Th e ground and fi rst fl oors of that magnifi cent and im-
posing block known as Alexandra Buildings are occu-
pied by the Hong Kong Dispensary, otherwise the well-
known fi rm of A. S. Watson & Co. Ltd., Chemists, 
Druggists, Aerated Water manufacturers, etc. Travellers 
passing through Hong Kong should pay a visit to the 
Hong Kong Dispensary where they may obtain every 
requisite for their voyage, including toilet articles, med-
icines, perfumery, tobacco, cigars and wines of the very 
fi nest quality, at prices that will compare favourably 
with those ruling at home or at any place along the 
route. Th e retail shop is fi t[ted] up in the most modern 
home style, and its stock is as complete as any of the 
largest contemporary establishment in London.3 
Humphreys participated in the rapid expansion of the 
retail pharmacy business soon after he joined Watson 
in 1889. In the same year, the Watson trademark was 
registered for use with 78 products as applied to wines, 
spirits, liquors, medicines, perfumes, aerated water, and 
other articles supplied by dispensing chemists and 
druggists in accordance with the Trade Mark Ordi-
nance 16 of 1873 and Ordinance 8 of 1886 in the col-
ony. “Anthelmintic Bonbons” were one of six medicinal 
products among the 78 products registered with the 
Watson’s trade mark (Figure 3).
By 1895, 35 dispensaries had been opened in China 
and 300 dispensary, toiletry and perfumery items were 
produced. Over 100 Watson’s pharmacy outlets had 
been opened in China and the Philippines by 1900. By 
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ing the period 1929-1932, dealt a severe blow to all 
businesses including Watson’s. In addition, fi ghting had 
arisen in Shanghai when the Japanese army entered the 
International Settlement on 28 January 1932. During 
that period A.S. Watson’s remained as the leading 
chemists and druggists in the colony (Table 1).4, 5 
then Watson had also become the sole distributor in the 
Far East for many well- known proprietary brands such 
as ‘Scott’s Fish Oil’ in its served markets.
When turmoil in China arose from the nationalist 
revolutionary army toppling the Qing imperial govern-
ment in 1911 Watson’s scaled back its investment in the 
mainland as well as closing its operations in the Philip-
pines. Humphreys therefore refocused his time and en-
ergy into building the Watson business in Hong Kong 
until the First World War erupted in Europe in 1914, 
during which the economy of Hong Kong as a trade 
and re-export also suff ered.
Business started to grow again in the early 1920s 
and Humphreys took the initiative to expand the busi-
ness in Taiwan by appointing a new distributor, “De-
shoutang”, which was an established herbal medicine 
shop in Taipei and traded as A. S. Watson to market 
‘Scott’s Fish Oil’ and a full range of Watson’s lines for 
the retail pharmacy market in Taiwan.
Business took a downturn in the late 1920s when 
global depression, beginning in the United States dur-
Figure 3. Watson’s Bonbons trademark registration, 1889 
(Source: Hong Kong Government Public Records Offi  ce)
Table 1. Watson’s Pharmacists in Hong Kong 
Number of pharmacists 
registered in Hong Kong 
in year 
1908 1916 1927 1936
Total number of pharmacists 13 19 24 27
Employed by A. S. Watson’s 8 12 13 8
% employed by Watson’s 62% 63% 54% 30%
Humphreys resigned at the end of the forty-eighth 
annual general meeting of Watson’s held on 21 March 
1933, and he was praised by the new chairman of the 
Board of Directors for his long association with the 
business he had helped to prosper over a period of 44 
years, not only in Hong Kong but throughout the Far 
East.6 
In addition to the pharmacy business with which 
he was directly involved Humphreys was also a member 
of the Board of Directors of John D. Humphreys & Son 
Ltd, the company that his father had created. He was 
also involved in the construction of the Peak Tramway 
in Hong Kong.
Humphreys was an active committee member of 
the Hong Kong General Chamber of Commerce, an 
expatriate business association during the colonial pe-
riod in the nineteenth and fi rst half of the twentieth 
centuries.
Humphreys’ public service 
Humphreys followed his father’s footsteps to become 
an unoffi  cial member of the Sanitary Board when he 
was elected uncontested for one of the two allocated 
seats in 1906. John David Humphreys had fi rst held 
the seat as an appointed position in the Sanitary Board 
some twenty years earlier.
During his three years’ tenure at the Sanitary Board 
Humphreys was appointed by Governor Matthew Na-
than as one of the three-member Public Health and 
Regulations Ordinance Commission in 1906 to inves-
tigate alleged corruption and bribery in the Sanitary 
Department. Th e fi ndings of the Commission led to 
the amendment of the Public Health and Building Or-
dinance in order to reform the Sanitary Board in 1908.7
During the First World War between 1914 and 1918 
Humphreys joined the Volunteers Corps and was be-
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stowed with the honour of Justice of the Peace in 1922 
in recognition of his contribution during the war.8
Humphreys’ family 
Humphreys was married to Alice (her maiden name is 
unknown) in Hong Kong the same year that he re-
turned from the United Kingdom, in 1889. Th e couple 
had three children, namely John David, Violet Chris-
tine, and Dorothy, before Alice died in 1895. John Da-
vid passed away at the age of 46 in Hong Kong in 1940.9 
Henry Humphreys remarried Eva Humphreys, report-
edly a cousin, at St John’s Cathedral in Central, Hong 
Kong Island on 12 April 1898. Th ey had a son, Ed-
mund Cecil, who migrated and settled in Bedford, 
England (Figure 4).10 
Th e Humphreys called their home “Th orpe” and 
spend many happy years developing it into one of 
the most attractive properties in the area, and he was 
a member of the Cowichan Country Club for many 
years. In 1939, the Humphreys sold their property 
and moved to Victoria, where they took up residence 
at the Empress Hotel. Humphreys became a mem-
ber of the nearby Union Club. 11 
Conclusion 
Henry Humphreys was born to an entrepreneurial fam-
ily in Hong Kong in 1867, trained as a pharmaceutical 
chemist in London and used his knowledge to the full-
est extent by growing the A. S. Watson chemist and 
druggist business in the late nineteenth century until 
his retirement in 1933. His journey was especially chal-
lenging given the turbulent times of the late Qing dy-
nasty, the transition to the Republican era, the First 
World War, and the Global Depression, amongst other 
monumental events.
As an educated and successful businessman in 
Hong Kong he lived the life of the British colonial elite, 
with active participation in the local businesses and so-
cial circles through his membership of the prestigious 
and exclusive gentlemen’s clubs such as the Royal Hong 
Kong Jockey Club. Humphreys was also a family man 
with four children; and he remained an avid tennis 
player even after retirement when he moved to Vancou-
ver, British Columbia in Canada.
Humphreys passed away at the age of 76 in 1943 in 
Vancouver, Canada leaving a legacy in retail pharmacy 
that is still being felt today. Humphrey’s vision of grow-
ing A. S. Watson’s as a global health and beauty cum 
pharmacy chain had fi nally been realized in 2016, with 
13,000 stores in 25 diff erent markets. Th e company’s 
national brands eventually included ‘Drogas’ in the 
Baltic states, ‘Kruidvat’ in the Benelux countries, 
‘Roosman’ in central Europe, ‘Savers’ and ‘SuperDrug’ 
in the United Kingdom, ‘Spektr’ in Russia, and ‘Trek-
pleister’ in the Netherlands, amongst others.
On the 175th anniversary in 2016 of its inception in 
1841, with the 2016 fi nancial report stating revenues of 
HKD 152 billion (£15billion or €17.9billion) there con-
tinue to be ambitious plans to expand Humphrey’s vi-
sion by opening over 1,000 stores annually.12 Th is phar-
macist was therefore a truly remarkable and global 
entrepreneur of his time in the late nineteenth and ear-
ly twentieth centuries.
Author’s address: Patrick Chiu, Hong Kong Society for 
the History of Pharmacy, 1104 Crawford House, 70 
Queens Road, Central, Hong Kong. E-mail: pchiuy@
netvigator.com
Figure 4. Family Tree of Henry Humphreys 
Humphreys’ hobbies and pastimes
Like many rich and famous people of his time in colo-
nial Hong Kong Humphreys held membership in sev-
eral gentlemen’s clubs. Th is would allow him to meet 
and exchange gossip with his contemporaries. Hum-
phreys was an avid tennis player, and he was also a 
member of the Royal Hong Kong Jockey Club. He was 
an active participant in the races at Happy Valley, and 
he owned several horses, like his father before him. He 
was also a member and frequent visitor to both the 
Cricket Club and the Yacht Club in Causeway Bay.
After retirement 
Henry planned for his retirement in 1918 at the age of 
51 when he went to Vancouver Island, British Colum-
bia, Canada for a vacation. In her book on Victorian 
houses, Valerie Green describes Grave Hall, Hum-
phreys’ retirement home in Vancouver Island:
In 1918 they came to the Cowichan Valley and pur-
chased the bungalow from Hirsch to use primarily 
as a summer cottage. Humphreys soon developed it 
into a grand, 22-room home with an Oriental fl avor. 
He also added a 21 by 30 foot billiard room and, 
being an avid gardener, he transformed the grounds 
into a spectacular oasis. Twelve Chinese gardeners 
were brought to Canada by Humphreys to work in 
the estate, and they lived in the bunkhouse behind 
the greenhouse.
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quence of his clash with the Pope over the question of 
his (Henry’s) attempted annulment of his marriage to 
Catherine of Aragon (his fi rst wife) and the resulting 
changes to the English Constitution. Th e Church of 
England, with Henry himself appointed as its supreme 
head, separated from papal authority and Henry fi lled 
his coff ers with the income and proceeds from the as-
sets resulting from his Dissolution of the Monasteries.
Th ese, and numerous other political machinations, 
ensured his place in history as an egotistical but char-
ismatic monarch, author and composer, who changed 
the face of England in numerous ways, and guaranteed 
his being the subject of many later plays, fi lms, biogra-
phies and novels. Portraits depicting him in later life 
reveal his obesity – his waist measured 54 inches 
(140cm) and he relied upon various mechanical aids 
(including the ‘king’s trams’ – eff ectively a type of se-
dan chair – for carrying him about the palace, and pos-
sibly also special hoists) to facilitate his mobility.
Henry VIII suff ered from numerous ailments at 
various times over his 55 years, some of which are well 
attested and others the source of speculation based 
upon the suite of symptoms which he exhibited at var-
ious times during his life. He was troubled by gout, for 
example, and also suff ered occasional bouts of consti-
pation. Th ere has been much discussion of a suggestion, 
originally posited in the 1920s, that he suff ered from 
syphilis; it is now generally agreed that was not the case.
Henry’s progressive obesity and accompanying 
changes, such as developing a moon-shaped face, plus 
his mental decline in later years, have brought about 
speculation that he may have suff ered from the endo-
crine abnormality Cushing’s Syndrome, to have been 
the consequence of Traumatic Brain Injury (TBI) sus-
tained during a jousting accident on 24 January 1546, 
or to be indicative of McLeod Syndrome (an X-linked 
recessive genetic disorder leading in turn to being Kell 
positive) for example. It has also been suggested that 
scurvy was a contributing factor in his death.
O’Caellaigh does not engage with these areas of dis-
cussion but selectively considers the somewhat safer 
ground of Henry’s experience with smallpox (1514), 
malaria (tertian fever; 1521), his ulcerated legs and var-
icose fi stula (1527 onwards), constipation (1539), and a 
series of accidents (two jousting accidents, in 1524 and 
again in 1536, and a mishap whilst playing tennis in 
1527). Following introductory remarks concerning the 
primary sources consulted, and contemporary theories 
of medicine, diagnosis and prescription, the author pro-
ceeds to address his chosen suite of ailments. Each con-
dition is considered in relation to the circumstances of 
Henry VIII’s life and times, often presenting interesting 
contemporary quotations from letters and other sourc-
Reviewed by Christopher J. Duffi  n
Publications concerning Tudor medicine are relatively 
few and far between, so the appearance of a new title 
dedicated to this particular time period in the history 
of medicine is worth a considered examination. Th e fo-
cus of this particular volume is King Henry VIII (1491-
1547), the illnesses, complaints and accidents from 
which he suff ered, and the contemporary remedies and 
treatments which might have been used to try to ame-
liorate his various conditions. Dedicating a volume to 
the ailments of a single monarch is unique, so far as I 
am aware, although treatments for royalty have been 
considered in Th e Royal Apothecaries by Leslie Matthews 
(1967), Th e Death of Kings by Cliff ord Brewer (2000), 
Royal Poxes and Potions by Raymond Lamont-Brown 
(2001) and Th e Royal Doctors, 1485-1714: Medical Per-
sonnel at the Tudor and Stuart Courts by Elizabeth Lane 
Furdell (2001). Th e publisher of this volume, Made-
Global Publishing, is a relatively new company, having 
been established only in 2012.
Henry VIII is an interesting character to have cho-
sen as a subject. He is, of course, well known from his-
tory lessons at school as the king who married six wives, 
who precipitated the English Reformation as a conse-
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es, and relevant background and contextualising infor-
mation.
Henry was actively interested in medical treat-
ments; something of a hypochondriac, he was intense-
ly inquisitive and applied his knowledge of the thera-
peutic properties of a wide range of medicinal plants to 
the practical development of around 100 receipts (or 
recipes) for various balms, ointments and poultices. He 
also retained the services of numerous medical person-
nel, including, at various times, famous names such as 
Th omas Linacre (1460-1524), Andrew Boorde (c.1490-
1549), John Chambre (1470-1549), Augustine de Au-
gustinis (dates unknown), William Butts (c.1485-1545) 
and Sir John Ayliff e (dates unknown).
In the absence of detailed records of actual treat-
ments for Henry, the author consults two main con-
temporary Tudor medical texts: Bullein’s Bulwarcke of 
Defence (1579) and Th omas Gale’s Certaine works of chi-
rurgerie (1563). William Bullein (c.1515-1576) is be-
lieved to have been a relative of Anne Boleyn, Henry’s 
second wife, and attended Henry as a ‘nurse-surgeon’. 
Th omas Gale (1507-1586) was not consulted by Henry 
so far as I am aware. O’Caellaigh chooses receipts ap-
propriate to the various symptoms and conditions suf-
fered by Henry during the progress of his various ail-
ments, as chosen by the author. The recipes are 
presented in both their original spelling and syntax, 
and then as more modern transcriptions for ease of ref-
erence. Th e components of the poly-pharmaceutical 
preparations are then considered in relation to contem-
porary understanding, and also in relation to a modern 
appreciation of the active ingredients in the most sig-
nifi cant of the herbal and other materials used, as well 
as some consideration of their potential contra-indica-
tions or demerits. Tudor medical terms and archaisms 
are suitably explained and useful background informa-
tion, explanation and wider contextual data are used in 
discussing the recipes and their ingredients. Th e text is 
supplemented by numerous informative endnotes and 
a bibliography.
Th is book provides an interesting insight into the 
prescribing practices of Tudor Britain. Intelligently 
written and presented, and supported by good quality 
photographic illustrations, this volume provides a use-
ful, well researched stepping off  point for further pur-
suit of the topic.
Reviewer’s Addresses: Dr Christopher J. Duffi  n, Scien-
tifi c Associate, Department of Earth Science, Palaeon-
tology Section, Th e Natural History Museum, Crom-
well Road, London SW7 5BD, UK, and 146 Church 
Hill Road, Sutton, Surrey, SM3 8NF, England.
Email: cduffi  n@blueyonder.co.uk.
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Leslie Matthews’ Drug Jar
Figure 1. Drug jar depicted in the Ex Libris of Leslie G. 
Matthews (Source: Royal Pharmaceutical Society Muse-
um, London, UK, Ref. 1997-50-4a)
Italian maiolica wet drug jar, dated 1605, of baluster 
form with strap handle, the spout with entwined 
support, painted in blue and manganese. Th e jar is 
labelled SY.DI.POMIS (syrupus de pomis composi-
tus regis saporis), which was a purgative syrup pre-
pared from apple juice, senna leaves and borage. Th e 
syrup was supposedly named after Sabor ibn Sahl, 
the 9th century Persian physician and compiler of 
the Krabadin, the fi rst known offi  cial pharmacopoe-
ia. Th e jar’s label is surmounted by an YHS mono-
gram and a cross, which was the mark of the Com-
pany of Jesuits. Th e jar is therefore likely to be from 
a monastic, possibly hospital dispensary of a Jesuit 
Order. Th e date on the jar is 1605.
We gratefully acknowledge this addendum and thank 
the museum’s staff  for their assistance.
Christiane Staiger, PhD, Neu-Isenburg, Germany. 
Email: ch.staiger@gmx.de
Peter G. Homan, Epsom, Surrey, UK. Email: 
p.g.homan2@btinternet.com
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Subsequent to our article on Leslie G. Matthews (1897-
1997)1 we became aware of further details. Staff  at the 
Museum of the Royal Pharmaceutical Society in Lon-
don informed us that the drug jar depicted in Mat-
thews’ Ex Libris (Figure 1) is now part of the museum’s 
collection.2 Th e jar came into the possession of the mu-
seum after Matthews’ death in 1997.3 It is 245mm high, 
195 mm wide and 165 mm deep. Th e database of the 
museum includes the following description:
https://doi.org/10.24355/dbbs.084-202007291249-0
